// App-Quantinova.ai

P418 : MODELLING AND TARGETING ACUTE MYELOID LEUKAEMIA CELLS IN THE BONE MARROW PROTECTIVE NICHE

Researchers

Presenter

  • Eleni E Ladikou

Principal Investigators

  • Kim Sharp

  • Thomas A Burley

  • Emma Kennedy

  • Timothy Chevassut

  • Chris Pepper

Medical Centers

  • Department of...

  • Department of Haematology,Brighton and Sussex University Hospital Trust,Brighton,Storbritannien

  • Clinical and Experimental Medicine,Brighton and Sussex Medical School,Brighton,Regno Unito

  • Clinical and Experimental Medicine,Brighton and Sussex Medical School,Brighton,Regno Unito

  • Department of Haematology,Brighton and Sussex University Hospital Trust,Brighton,Storbritannien

  • Department of Haematology,Brighton and Sussex University Hospital Trust,Brighton,Storbritannien

  • Department of Haematology,Brighton and Sussex University Hospital Trust,Brighton,Storbritannien

  • Clinical and Experimental Medicine,Brighton and Sussex Medical School,Brighton,Regno Unito

  • Clinical and Experimen

  • Clinical and Experimental Medicine,Brighton and Sussex Medical School,Brighton,Regno Unito

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute myelocytic leukemia

Biomarkers

  • C-X-C motif chemokine receptor 4

Drug/Treatment

  • Natalizumab

  • Plerixafor

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A